What are the indications for referring a patient for pulmonary function testing (PFT) to evaluate asthma versus restrictive airway syndrome (RAS)?

PFT Referral Indications: Asthma vs Restrictive Airway Disease

Refer for PFT when you suspect asthma based on episodic symptoms (wheeze, cough, dyspnea, chest tightness) that worsen with triggers, OR when you suspect restrictive disease based on reduced lung volumes without reversibility—spirometry with bronchodilator testing is the essential first step for both conditions. 1, 2, 1

Core Principle: Objective Testing is Mandatory

The fundamental issue is that objective lung function testing is required to confirm any respiratory diagnosis—you cannot rely on history and physical examination alone 1, 2. The 2024 GINA guidelines and EPR-3 explicitly state that spirometry is essential because medical history and physical examination are unreliable for excluding other diagnoses 1, 2.

When to Refer for Asthma Evaluation

Primary Indications:

• Episodic symptoms: Recurrent wheeze, cough (especially nocturnal), dyspnea, or chest tightness 2
• Trigger-related symptoms: Worsening with exercise, viral infections, allergens, irritants, weather changes, or strong emotions 2
• Suspected asthma without prior objective confirmation: 75% of asthma patients in primary care lack PFT confirmation of diagnosis 1

Specific Testing Approach for Asthma:

1. Baseline spirometry (age ≥5 years): Look for FEV₁/FVC <70% (adults) or <85% (children 5-18 years) 2
2. Bronchodilator responsiveness: Increase in FEV₁ ≥12% AND ≥200 mL after 400 μg short-acting β₂-agonist confirms reversible obstruction 1, 3
3. If spirometry is normal but suspicion remains: Bronchoprovocation testing (methacholine, exercise challenge) to detect airway hyperresponsiveness 2
4. Serial measurements: Because asthma is variable, one normal test doesn't exclude the diagnosis—repeat testing may be needed 3

Critical Pitfall:

Negative bronchodilator response does NOT exclude asthma 3. Patients with well-controlled asthma often have normal spirometry between episodes 3.

When to Refer for Restrictive Disease Evaluation

Primary Indications:

• Reduced FVC with normal or high FEV₁/FVC ratio (>70%) on initial spirometry 2, 4
• Clinical findings suggesting restriction: Chest wall deformity, neuromuscular disease, interstitial lung disease symptoms, or unexplained dyspnea 2
• Hypoxemia on pulse oximetry without clear obstructive pattern 5

Specific Testing Approach for Restriction:

1. Initial spirometry shows: FVC <80% predicted (or below 5th percentile) with FEV₁/FVC ≥70% 4
2. Full PFT with lung volumes required: Must measure total lung capacity (TLC) by plethysmography or gas dilution to confirm true restriction 2, 4
3. Diffusing capacity (DLCO): Essential to differentiate parenchymal disease from chest wall/neuromuscular causes 2, 5
4. Additional tests by pulmonologist: Maximal inspiratory/expiratory pressures (respiratory muscle strength), chest radiograph, and potentially peak cough flow 5

Critical Distinction—True vs Pseudo-Restriction:

Beware of "pseudorestriction" in asthma: Some asthmatic patients show reduced FVC due to air trapping (increased RV/FRC), not true restriction 6, 7. This requires plethysmographic lung volumes to differentiate—if FRC/RV are elevated, it's air trapping from obstruction, not restriction 6. True restrictive impairment in asthma (reduced TLC without increased RV) occurs in approximately 8% of asthmatics and should not preclude asthma diagnosis or treatment 6.

Mixed Pattern Recognition

If both FEV₁/FVC ratio AND FVC are low: The patient has a mixed obstructive-restrictive defect requiring full PFT with lung volumes and DLCO to characterize both components 2, 4.

Practical Algorithm

Step 1: Clinical Assessment

• Episodic/trigger-related symptoms → suspect asthma
• Progressive dyspnea with reduced exercise tolerance, no reversibility → suspect restriction
• Recurrent pneumonia (>2 treated or 1 hospitalized) → refer to specialist 5

Step 2: Initial Spirometry

• Obstructive pattern (FEV₁/FVC <70%) → bronchodilator testing
  • Positive response (≥12% and ≥200 mL increase) = asthma
  • No response = consider COPD, need DLCO to differentiate 2
• Restrictive pattern (FVC <80%, FEV₁/FVC ≥70%) → full PFT with lung volumes and DLCO mandatory 4
• Normal spirometry but high clinical suspicion → bronchoprovocation testing 2

Step 3: Specialist Referral Triggers

• Abnormal spirometry requiring full PFT (restrictive pattern)
• Normal spirometry needing bronchoprovocation
• Diagnostic uncertainty after initial testing
• Severe or difficult-to-control disease 1

Key Caveats

Age considerations: Spirometry is reliable in patients ≥5 years; younger children require specialized assessment 2, 8. Bronchoprovocation should only be performed by trained personnel for safety 2, 8.

Equipment matters: Peak flow meters are for monitoring, NOT diagnosis—always use spirometry for diagnostic purposes 2.

Timing issues: Withhold bronchodilators appropriately before testing (short-acting 8 hours, long-acting 48 hours) and ensure patient is 3 weeks post-respiratory infection 8.